PepGen Inc
NASDAQ:PEPG
Earnings Announcements
PepGen Reports First Quarter 2022 Financial Results And Recent Corporate Developments
Published: 06/16/2022 12:39 GMT
PepGen Inc (PEPG) - Pepgen Reports First Quarter 2022 Financial Results and Recent Corporate Developments.
Q1 Loss per Share $18.94.
Pepgen-look Forward to Reporting Safety, Pharmacokinetic and Exon Skipping Data From Phase 1 Healthy Normal Volunteer Study of Pgn-edo51 by End 2022.
Q1 Loss per Share $18.94.
Pepgen-look Forward to Reporting Safety, Pharmacokinetic and Exon Skipping Data From Phase 1 Healthy Normal Volunteer Study of Pgn-edo51 by End 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.76
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.76
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.76
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.76
More details on our Analysts Page.